Testosterone-Only Cycle: The Reference First Protocol
Getting Started · 5 min read · Updated on May 23, 2026
The testosterone-only cycle is the reference protocol for a first run. This guide walks through its structure: ester choice, typical length, injection frequency, and what goes around it (PCT, bloods, estrogen management). It does not give a personal "recipe" — for that, see each compound page — but it lays out the logic of the protocol and the trade-offs that built it.
For the why of running testosterone only on a first cycle and the prerequisites to clear before starting, read the first steroid cycle pillar first. This page is the operational mechanics.
Choosing an ester: enanthate, cypionate or propionate
The "ester" is the carbon chain attached to the testosterone molecule that governs how fast it releases into the bloodstream. The longer the ester, the slower the release and the longer the half-life [5]. The testosterone is the same in every case — only the kinetics change.
| Ester | Half-life | Frequency | Profile |
|---|---|---|---|
| Enanthate (Test E) | 4.5 days | 2× / week | Standard, steady signal, the most common first-cycle pick |
| Cypionate (Test Cyp) | 5 days | 2× / week | Almost interchangeable with enanthate, dominant in the US |
| Propionate (Test Prop) | 2 days | Every other day | Sharper peaks and troughs, more pins, often more painful |
For a first cycle, the default pick is enanthate (Test E) or cypionate (Test Cyp). The two are essentially interchangeable [1]. Propionate (Test Prop) demands more frequent pinning (every other day), tends to be more painful at the injection site, and offers little upside for a beginner. To see how these half-lives translate into actual serum concentrations day by day, the half-life calculator shows the curve.
Dose and length: what the community ranges actually say
The standard beginner range for a testosterone-only cycle sits inside the dose window listed on the testosterone enanthate compound page, split across two weekly injections. That is the "contained dose" the pillar talks about: high enough to deliver real effects, low compared to what you see in advanced cycles, and leaving headroom for cycles down the road.
Why not push higher "to get there faster"
- The gains-to-dose curve plateaus early: doubling the dose does not double the gains, but it does double the side effects (hematocrit, estradiol, suppression, blood pressure) [2].
- Without a baseline blood panel at the minimum effective dose, you have no read on how your body responds. No point testing a high dose before you have validated a low one.
- Progression room between cycles is built. Starting too high condemns you to ever-higher doses to feel anything on the next cycle.
Length: 10 to 16 weeks
A long-ester cycle typically runs 10 to 16 weeks. Under 10 weeks on a long ester, the benefit is marginal — it takes 4 to 6 weeks just to reach steady-state [1]. Past 16 weeks, suppression deepens and HPTA recovery takes longer. For a first cycle, 12 weeks is a common balance point.
Injection frequency: why twice a week
With a long ester at a 4 to 5-day half-life, a single weekly injection creates a peak followed by a marked drop — which translates into estradiol swings, end-of-week fatigue and an inconsistent ride. Two pins per week (e.g. Monday and Thursday) smooth that signal without adding a meaningful practical burden.
On gear and technique: fine needles for the actual injection (typically 23–25G for intramuscular), wider draw needles for the vial, rigorous antisepsis, and site rotation (delts, quads, glutes, ventroglute). The how to inject steroids guide covers sites, rotation and sterile practice.
What goes around it: PCT, AI, HCG
PCT, planned before the first injection
For a long ester, post-cycle therapy (PCT) starts 2 to 3 weeks after the last injection. The standard protocol uses a SERM — typically Nolvadex at 40/40/20/20 mg over 4 weeks, or Clomid at 50/50/25/25 over 4 weeks. The compounds are sourced and in hand before the first pin — not during the cycle.
AI: dose to bloods, do not run it on autopilot
Testosterone aromatizes into estradiol — that is normal and useful at physiological levels. On cycle, estradiol can climb above target and drive breast tenderness, water retention, and a libido dip. The current approach is to measure estradiol on bloods and only introduce an AI if values run out of range with clinical signs. A default AI dose with no measurement is the classic mistake: a crashed estradiol creates more problems than a slightly elevated one.
HCG: optional on a short first cycle, useful past 14 weeks
On a 10 to 12-week first cycle, HCG on-cycle (e.g. 250–500 IU twice a week) is optional: it preserves testicular volume and smooths recovery, but it is not mandatory [3]. Past 14 to 16 weeks, or with marked testicular atrophy, the case for it grows. The detail is in the HCG on cycle and PCT guide.
On-cycle monitoring
Three numbers to track during the cycle: hematocrit (thrombotic risk — testosterone drives erythropoiesis), estradiol (to decide whether to dose an AI), the lipid panel (HDL/LDL) [4]. Add blood pressure to that list — measurable at home with a reliable automatic cuff.
The mid-cycle panel is typically scheduled around week 4 to 6: late enough that levels are stable, early enough to still adjust. The full marker breakdown and target ranges sit in the blood work on cycle guide.
Frequently asked questions
Test E or test cyp: does the choice actually matter?
No clinically meaningful difference for most users. Cypionate has a slightly longer half-life, but injection frequency is the same (twice weekly). Pick by source availability and quality, not by the molecule.
How long before you feel a long-ester cycle?
On a long ester, serum levels reach steady-state between week 4 and week 6. The first noticeable effects (recovery, strength, well-being) usually show up around week 3 or 4; mass gains build over the following 8 to 12 weeks. A long-ester cycle does not "kick in" in a few days — that is why the recommended minimum length is 10 weeks.
Should you kickstart a first cycle with an oral?
Not on a first cycle. A kickstart means adding an oral (typically Dianabol) over the first 4 to 6 weeks to compensate for the slow ramp of a long ester. It is an option for intermediate cycles, but it adds hepatotoxicity and a side-effect layer that is not necessary on a first run. A first cycle uses a single compound.
Sources
Studies and scientific publications this guide relies on.
- Schulte-Beerbühl M, Nieschlag E (1980). Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate. Fertility and Sterility. doi: 10.1016/s0015-0282(16)44543-7
Étude comparative pharmacocinétique entre énanthate et cypionate de testostérone après injection intramusculaire chez l'homme : profils sériques quasi superposables, demi-vies de l'ordre de 4 à 5 jours.
- Bhasin S, Woodhouse L, Casaburi R, et al. (2001). Testosterone dose-response relationships in healthy young men. American Journal of Physiology - Endocrinology and Metabolism. doi: 10.1152/ajpendo.2001.281.6.E1172
Étude dose-réponse chez 61 hommes eugonadaux recevant 25, 50, 125, 300 ou 600 mg/sem d'énanthate sur 20 semaines (axe HPT supprimé par GnRH-agoniste). Gains de masse maigre et de force dose-dépendants, mais hématocrite et lipides dégradés aux doses hautes.
- Coviello AD, Matsumoto AM, Bremner WJ, et al. (2005). Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2004-0802
RCT démontrant que 250 UI de hCG tous les deux jours, ajoutées à 200 mg/sem de testostérone énanthate, maintiennent la testostérone intratesticulaire proche du baseline (-7 %) vs effondrement (-57 %) sous testostérone seule.
- Anawalt BD (2019). Diagnosis and Management of Anabolic Androgenic Steroid Use. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2018-01882
Revue clinique couvrant l'évaluation et la prise en charge des utilisateurs de stéroïdes androgéniques : suppression de l'axe HPT, érythropoïèse dose-dépendante, marqueurs hépatiques et lipidiques à surveiller.
- Kicman AT (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology. doi: 10.1038/bjp.2008.165
Revue de référence sur la pharmacologie des stéroïdes anabolisants : structure, esters, pharmacocinétique, mécanismes d'action et conséquences cliniques.
Guides liés
Molécules citées
Calculateurs utiles
Track your cycle with real data
Daily journal, 52 compounds, blood work and AI analysis — to apply what you just read and track results cycle after cycle.
Free 5-day trial — no credit card